🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as trastuzumab, can block tumor grow...
Status
Completed
Location
Kantonspital Aarau
Start Date
2005-05
Trial ID
NCT00238290
Treatments Being Tested
In this single arm, open label, phase 2 trial, operable patients with stage...
Status
Unknown
Location
Yantai Yuhuangding Hospital
Start Date
2022-08-04
Trial ID
NCT05800756
Treatments Being Tested
A study to compare the safety and efficacy of an aromatase inhibitor in com...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05-05
Trial ID
NCT01160211
Treatments Being Tested
Observational investigation of participants who are given neoadjuvant treat...
Status
Not Yet Recruiting
Location
National Institute of Oncolgy
Start Date
2022-03
Trial ID
NCT05131893
This prospective, response-adapted phase II study evaluates the efficacy an...
Status
Recruiting
Location
The First Affiliated Hospital of Nanjing Medical University
Start Date
2026-05-20
Trial ID
NCT07616427
Treatments Being Tested
The goal of this clinical trial is to compare trastuzumab deruxtecan (T-DXd...
Status
Recruiting
Location
Skåne University Hospital
Start Date
2023-10-26
Trial ID
NCT05900206
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
SMMART-ACT is a feasibility pilot study to determine if testing samples fro...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01-30
Trial ID
NCT05238831
Treatments Being Tested
This randomized, open-label, two-arm, multi-center, Phase II study will eva...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2012-02-17
Trial ID
NCT01491737
Treatments Being Tested
This is an open-label, multicenter, Phase I study designed to evaluate the ...
Status
Active Not Recruiting
Location
Massachusetts General Hospital.
Start Date
2016-12-13
Trial ID
NCT03006172
Treatments Being Tested